HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warakaulle, D. R. Articles by Gleeson, F. Search for Related Content PubMed PubMed Citation Articles by Warakaulle, D. R. Articles by Gleeson, F. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

MDCT Appearance of Gastrointestinal Stromal Tumors After Therapy with Imatinib Mesylate

¹ Both authors: Department of Radiology, The Churchill Hospital, Old Road, Oxford, OX3 7LJ, United Kingdom.

OBJECTIVE. Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate.

CONCLUSION. Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.

Keywords: CT • gastrointestinal imaging • gastrointestinal stromal tumors • imatinib mesylate • oncologic imaging

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Wronski, W. Cebulski, M. Slodkowski, and I. W. Krasnodebski Gastrointestinal Stromal Tumors: Ultrasonographic Spectrum of the Disease J. Ultrasound Med., July 1, 2009; 28(7): 941 - 948. [Abstract] [Full Text] [PDF]